The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response

Checkpoint blockade therapies have changed the clinical management of metastatic melanoma patients considerably, showing survival benefits. Despite the clinical success, not all patients respond to treatment or they develop resistance. Although there are several treatment predictive biomarkers, unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabrita, Rita, Mitra, Shamik, Sanna, Adriana, Ekedahl, Henrik, Lövgren, Kristina, Olsson, Håkan, Ingvar, Christian, Isaksson, Karolin, Lauss, Martin, Carneiro, Ana, Jönsson, Göran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140048/
https://www.ncbi.nlm.nih.gov/pubmed/32245160
http://dx.doi.org/10.3390/cancers12030742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140048/
https://www.ncbi.nlm.nih.gov/pubmed/32245160
http://dx.doi.org/10.3390/cancers12030742

Ejemplares similares